title: Use of ticagrelor in human pregnancy, the first experience.
abstract: Ticagrelor was daily administered throughout pregnancy to a 37-year-old pregnant woman until 36 weeks of gestation. The patient, with Behçet disease, suffered from a non-ST elevation myocardial infarction 4 months before conception, possibly related to hypertension and tobacco abuse. Pregnancy and postpartum periods were uneventful. She delivered a healthy but small-for-gestational-age term neonate.
authors.affiliation: Department of Obstetrics, UZA, Edegem, Belgium.
authors.forename: Marjan
authors.initials: M
authors.lastname: Verbruggen
authors.affiliation: Department of Obstetrics, UZA, Edegem, Belgium.
authors.forename: Dominique
authors.initials: D
authors.lastname: Mannaerts
authors.affiliation: Department of Obstetrics, UZA, Edegem, Belgium.
authors.forename: Joke
authors.initials: J
authors.lastname: Muys
authors.affiliation: Department of Obstetrics, UZA, Edegem, Belgium.
authors.forename: Yves
authors.initials: Y
authors.lastname: Jacquemyn
mesh_terms: D000241:Adenosine / Q000031:analogs & derivatives* / Q000627:therapeutic use; D000328:Adult; D001241:Aspirin / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D009203:Myocardial Infarction / Q000150:complications / Q000628:therapy; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use*; D011247:Pregnancy; D011248:Pregnancy Complications / Q000517:prevention & control*; D058921:Purinergic P2Y Receptor Antagonists / Q000627:therapeutic use*; D055502:Secondary Prevention; D013923:Thromboembolism / Q000517:prevention & control*; D000077486:Ticagrelor
chemical_list: D010975:Platelet Aggregation Inhibitors; D058921:Purinergic P2Y Receptor Antagonists; D000077486:Ticagrelor; D000241:Adenosine; D001241:Aspirin